Cure of Apparent Mineralocorticoid Excess by Kidney Transplantation
Authors:
- Mario PalermoMPMario Palermo
- Maria CossuMCMaria Cossu
- Cedric H.L. ShackletonCSCedric H.L. Shackleton
- 10 December 1998
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 339 (24) , 1787-1788
Abstract
Kidney 11β-hydroxysteroid dehydrogenase 2 protects against mineralocorticoid excess by oxidatively converting cortisol, which binds to mineralocorticoid receptors as well as does aldosterone, to cortisone. Loss-of-function mutations in the gene for this enzyme cause the syndrome of apparent mineralocorticoid excess, with severe hypertension and hypokalemia.1,2 Most patients with the syndrome can be treated effectively with mineralocorticoid-receptor antagonists, potassium-sparing diuretics, and dexamethasone. We describe a woman with apparent mineralocorticoid excess who was cured by renal transplantation.Keywords
This publication has 4 references indexed in Scilit:
- A genetic defect resulting in mild low-renin hypertensionProceedings of the National Academy of Sciences, 1998
- Molecular Basis for Hypertension in the “Type II Variant” of Apparent Mineralocorticoid ExcessThe American Journal of Human Genetics, 1998
- Urinary free cortisone and the assessment of 11β‐hydroxysteroid dehydrogenase activity in manClinical Endocrinology, 1996
- Apparent Mineralocorticoid ExcessHypertension, 1996